iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies, Inc.

iRhythm Technologies offers uninterrupted ambulatory cardiac monitoring services using the Zio monitor to help diagnose cardiac arrhythmias.

COM:IRHYTHMTECH

iRhythm Technologies

Last Close

73.90

22/11 21:00

Market Cap

2.95B

Beta: -

Volume Today

420.00K

Avg: -